Medicine & TechnologyScientists from Sechenov University said they have already finished human trials for a coronavirus vaccine and results have proven the medication's effectiveness. But there are no reports yet on its commercial reproduction.
The United States has invested $42 million into producing syringes and needles in anticipation of the future coronavirus vaccine. The US President is hopeful that a vaccine could be ready by the end of the year or early next year.
Scientists recreate human cell membranes onto an electronic chip to measure its behavior with external substances such as viruses and antibiotics. Soon, it will be screening drug candidates for coronavirus.
The relationship between blood platelets and viral infection is clarified in a recent study. Further research is needed to see how platelets help the immune system fight viruses such as COVID-19, and how these findings may help with vaccine developments.
A reverse genetics system was used to create and study a mutant version of the highly contagious rotavirus. The initial steps of viral assembly gave valuable insight on what may trigger virus multiplication.
Scientists have made a breakthrough discovery in the field of vaccine development. The new study claims that the researchers have identified and eliminated the cause of Vaccine-enhanced Disease in Mycoplasma pneumoniae.
Pharmacist-administered vaccinations were observed to be under-reporting immunization records. Health authorities express the effect that incomplete records may have when the coronavirus vaccine becomes available.
Chinese respiratory experts said that the CDC in China is already drafting guidelines to determine who would be eligible to receive the vaccine, when to take it, and what qualifies an emergency situation.
Ian Haydon was among the three volunteers given the highest dose of the candidate vaccine from Moderna Therapeutics. He had adverse reactions, while another was given a lower dose and developed a rash.